Crawford Nomination Heads For Committee Vote, But Obstacles Remain
This article was originally published in The Gray Sheet
Executive Summary
The Senate Health committee has scheduled a June 15 vote on the nomination of FDA Commissioner-designee Lester Crawford, following an HHS Inspector General investigation clearing him of allegations of misconduct